Tag: AMO Pharma

AMO Pharma Announces Launch of First Clinician-Completed Rating Scale for Congenital Myotonic Dystro...

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, today annou...